New Aspects in the Diagnosis and Treatment of Hodgkin’s Disease: First International Symposium on Hodgkin's Lymphoma in Cologne, October 2-3, 1987: Recent Results in Cancer Research, cartea 117
Editat de Volker Diehl, Michael Pfreundschuh, Markus Loeffleren Limba Engleză Paperback – 19 ian 2012
Din seria Recent Results in Cancer Research
- 5% Preț: 845.19 lei
- 5% Preț: 191.69 lei
- 5% Preț: 782.46 lei
- 5% Preț: 913.76 lei
- 5% Preț: 919.23 lei
- 5% Preț: 400.28 lei
- 15% Preț: 490.42 lei
- 5% Preț: 703.83 lei
- 5% Preț: 721.05 lei
- 5% Preț: 709.35 lei
- 5% Preț: 711.15 lei
- 5% Preț: 710.60 lei
- 5% Preț: 713.33 lei
- 5% Preț: 361.80 lei
- 5% Preț: 712.60 lei
- 5% Preț: 371.10 lei
- 5% Preț: 721.96 lei
- 5% Preț: 716.84 lei
- 5% Preț: 356.32 lei
- 5% Preț: 719.74 lei
- 5% Preț: 717.56 lei
- 5% Preț: 359.60 lei
- 5% Preț: 706.41 lei
- 5% Preț: 717.73 lei
- 5% Preț: 719.19 lei
- 5% Preț: 705.32 lei
- 5% Preț: 717.20 lei
- 5% Preț: 711.15 lei
- 5% Preț: 712.25 lei
- 5% Preț: 710.96 lei
- 5% Preț: 378.97 lei
- 5% Preț: 1089.68 lei
- 5% Preț: 361.06 lei
- 5% Preț: 712.25 lei
- 5% Preț: 715.55 lei
- 5% Preț: 716.84 lei
- 5% Preț: 720.68 lei
- 5% Preț: 707.86 lei
- 5% Preț: 732.01 lei
- 5% Preț: 715.91 lei
- 5% Preț: 723.05 lei
- 5% Preț: 369.10 lei
- 5% Preț: 709.35 lei
- 5% Preț: 712.60 lei
- 5% Preț: 711.52 lei
- 5% Preț: 719.38 lei
- 5% Preț: 709.14 lei
- 5% Preț: 710.06 lei
- 5% Preț: 724.70 lei
Preț: 718.29 lei
Preț vechi: 756.09 lei
-5% Nou
Puncte Express: 1077
Preț estimativ în valută:
137.46€ • 142.64$ • 114.89£
137.46€ • 142.64$ • 114.89£
Carte tipărită la comandă
Livrare economică 15-29 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642837838
ISBN-10: 3642837832
Pagini: 300
Ilustrații: XIV, 283 p.
Dimensiuni: 170 x 242 x 16 mm
Greutate: 0.48 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Recent Results in Cancer Research
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642837832
Pagini: 300
Ilustrații: XIV, 283 p.
Dimensiuni: 170 x 242 x 16 mm
Greutate: 0.48 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Recent Results in Cancer Research
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
Pathology and Cell Biology of Hodgkin’s Disease.- Pathology of Hodgkin’s Disease: Anything New?.- Immunology of Hodgkin and Reed-Sternberg Cells.- DNA Gene Rearrangement Studies in Hodgkin’s Disease and Related Lymphomas: A Contribution to Their Cellular Origin..- Genetics of Hodgkin’s Lymphoma.- Hodgkin’s Disease Derived Cell Lines.- Biology of Hodgkin Cell Lines.- Phenotypic and Genotypic Analysis of Two Cell Lines Derived from Hodgkin’s Disease Tissue Biopsies.- The Typical Reed-Sternberg Phenotype and I g Gene Rearrangements of Hodgkin’s Disease Derived Cell Line ZO Indicating a B-Cell Origin.- Characterization of Hodgkin’s Disease Derived Cell Line HDLM-2.- A New Hypothesis on the Cellular Origin of Reed-Sternberg and Hodgkin Cells Based on the Immunological and Molecular Genetic Analysis of the KM-H2 Line.- A Marker and Putative Pathoantigen of Hodgkin’s Cells.- Development in Diagnostic Procedures.- Radiolabeled Monoclonal Antibodies Against Reed-Sternberg Cells for in Vivo Imaging of Hodgkin’s Disease by Immunoscintigraphy.- Diagnostic Strategies and Staging Procedures for Hodgkin’s Lymphoma: Bone Marrow Scintigraphy and Magnetic Resonance Imaging.- Therapeutic Strategies.- Overviews.- Radiotherapy Trials in Hodgkin’s Disease.- Current Status of Chemotherapy for Hodgkin’s Disease.- Report on Recent and Current Clinical Trials.- Risk Factor Adapted Treatment of Hodgkin’s Lymphoma: Strategies and Perspectives.- Reduced Combined Radiotherapy and Chemotherapy for Hodgkin’s Disease — Risk-Adapted Treatment Approach.- Hodgkin’s Disease: The Milan Cancer Institute Experience with MOPP and ABVD.- EORTC Lymphoma Cooperative Group Studies in Clinical Stage I-II Hodgkin’s Disease — 1963 1987.- Current Stanford Clinical Trials forHodgkin’s Disease.- Results and Prognostic Factors Following Optimal Treatment in Advanced Hodgkin’s Disease.- Two Cycles of MOPP and Definitive Radiotherapy for Stage IIIA and III B Hodgkin’s Disease.- Risk Factor Adapted Treatment of Hodgkin’s Lymphoma in Childhood: Strategies and Results of Three Consecutive Multicenter Studies in the Federal Republic of Germany.- Hodgkin’s Disease in Children: Adaptation of Treatment to Risk Factors.- Role of Bone Marrow Transplantation in the Treatment of Hodgkin’s Lymphoma.- Conventional Salvage Therapy for Hodgkin’s Lymphoma.- High-Dose Combination Chemotherapy with Cyclophosphamide, Carmustine, Etoposide, and Autologous Bone Marrow Transplantation in 60 Patients with Relapsed Hodgkin’s Disease: The M. D. Anderson Experience.- Treatment of Resistant Hodgkin’s Lymphoma with Bone Marrow Transplantation in Italy.- Preliminary Results of Autologous Bone Marrow Transplantation in the Management of Resistant Hodgkin’s Disease: Experience of the Bloomsbury Transplant Group at University College, London.- Bone Marrow Transplantation in the Treatment of Hodgkin’s Lymphoma: Problems, Remaining Challenges, and Future Prospects.- Acute and Late Side Effects of Treatment.- Quality of Life During and After Treatment of Hodgkin’s Disease.- Risk of Secondary Acute Leukemia and Preleukemia After Hodgkin’s Disease: The Institut Gustave-Roussy Experience.